Abstract Purpose of Review Endoscopic injection of bulking agents for the treatment of
vesicoureteral reflux (VUR) has become a therapeutic alternative to antibiotic prophylaxis …

Background & aims There are conflicting reports on the efficacy of bulking agents for vesico
ureteric reflux (VUR). In this meta-analysis we have compared the outcomes of endoscopic …

Objective To evaluate an outcome of endoscopic correction of vesicoureteral reflux (VUR)
using Vantris (Promedon, Cordoba, Argentina) in terms of its effectiveness and morbidity in a …

Background It is extremely important to not only address the short-term success following
endoscopic correction of vesicoureteral reflux (VUR) but also the long-term efficacy and …

Abstract Background Dextranomer/hyaluronic acid (Dx/Ha; Dexell®) and polyacrylate-
polyalcohol copolymer (PPC; Vantris®) are the popular tissue-augmenting substances using …

Results Follow-up was completed in 89.6% of patients (112 children), and 89.8% of RRUs
(177 out of 197). Reflux resolved in 86.4% of RRUs after single injection, in 99.4% after …

Vesicoureteral reflux (VUR) is a disorder that has been studied since the early days of
pediatric urology. From 1893, when it was first documented in humans by Pozzi, the …

Objective To compare the radiological and clinical outcomes of endoscopic treatment of
primary VUR using polyacrylate-polyalcohol copolymer (PPC-Vantris®) or dextranomer …

Purpose Our study aimed to compare the efficacy of polyacrylate polyalcohol copolymer and
Dextranomer-Hyaluronic Acid for endoscopic treatment of vesicoureteral reflux. Material and …

Purpose We aimed at evaluating the efficacy and complications of two bulking substances:
dextranomer/hyaluronic acid copolymer (Dx/Ha; Dexell®) versus polyacrylate polyalcohol …